FoldRx Pharmaceuticals, Inc.
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 14, 2013 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 109 Total Citation Count
- May 20, 2005 Earliest Filing
- 6 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8440705 Compounds, compositions and methods of inhibiting alpha-synuclein toxicitySep 16, 05May 14, 13[A61K, C07D]
8338459 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfoldingDec 28, 10Dec 25, 12[A61K, C07D]
7868033 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfoldingMay 20, 05Jan 11, 11[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0305,068 COMPOUNDS AND METHODS FOR MODULATING PROTEIN TRAFFICKINGAbandonedNov 09, 07Dec 02, 10[A61K]
2010/0273,776 INHIBITION OF ALPHA-SYNUCLEIN TOXICITYAbandonedMar 29, 07Oct 28, 10[A61K, C07D, C12N, A61P]
2010/0122,362 CELLS EXPRESSING ALPHA-SYNUCLEIN AND USES THEREFORAbandonedOct 12, 07May 13, 10[A61K, C12N, A01K, G01N, A61P]
2010/0004,277 COMPOUNDS AND METHODS FOR MODULATING PROTEIN TRAFFICKINGAbandonedJan 26, 07Jan 07, 10[A61K, C12P, C07D, G01N, A61P]
2008/0131,907 ASSAYS FOR DETECTING NATIVE-STATE PROTEINS AND IDENTIFYING COMPOUNDS THAT MODULATE THE STABILITY OF NATIVE-STATE PROTEINSAbandonedSep 14, 07Jun 05, 08[G01N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.